21324454

Niccoli G

2011

CD4+CD28 null T lymphocytes are expanded in young women with polycystic ovary syndrome.

21325046

Hogg K

2011

Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary.

21325466

Tfayli H

2011

Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.

21325745

Koiou E

2011

The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome.

21328294

Moran LJ

2011

Lifestyle changes in women with polycystic ovary syndrome.

21329419

Naka KK

2011

Effect of ethinylestradiol/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study.

21331030

Birnbaum MJ

2011

Genomics: Drugs, diabetes and cancer.

21332919

Zainab J

2011

Laser hair removal in a patient with polycystic ovarian syndrome and vitiligo.

21333983

Ganie MA

2011

Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome.

21335359

de Groot PC

2011

PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis.

21339935

Badawy A

2011

Treatment options for polycystic ovary syndrome.

21352077

de Sousa G

2011

A comparison of polysomnographic variables between adolescents with polycystic ovarian syndrome with and without the metabolic syndrome.

21353371

Katsikis I

2011

Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.

21353671

Jungheim ES

2011

Associations between free fatty acids, cumulus oocyte complex morphology and ovarian function during in vitro fertilization.

21353673

Kucherov A

2011

Aromatase inhibition causes increased amplitude, but not frequency, of hypothalamic-pituitary output in normal women.

21355294

Zhang F

2011

[The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome].

21357181

Crete J

2011

Managing polycystic ovary syndrome: what our patients are telling us.

21358414

Schlaich MP

2011

Renal denervation: a potential new treatment modality for polycystic ovary syndrome?

21362574

Glueck CJ

2011

Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years.

21366130

Coksuer H

2011

Effects of hyperandrogenism on tear function and tear drainage in patients with polycystic ovary syndrome.

21366813

Brufani C

2011

Use of metformin in pediatric age.

21372710

Lalioti MD

2011

Impact of follicle stimulating hormone receptor variants in fertility.

21374548

Bals-Pratsch M

2011

Early onset and high prevalence of gestational diabetes in PCOS and insulin resistant women before and after assisted reproduction.

21374929

Visnovsk? J

2010

[Hormonal treatment effectivity in hyperandrogenic syndrome].

21375143

Unfer V

2010

Polycystic ovary syndrome: a vitamin deficiency? Floating a new pathogenesis hypothesis.

21376483

Kang HS

2011

The use of acupuncture for managing gynaecologic conditions: An overview of systematic reviews.

21385417

Egan N

2011

Evaluating compliance to a low glycaemic index (GI) diet in women with polycystic ovary syndrome (PCOS).

21385809

Dyer C

2011

Doctor who injected her sister with unlicensed drug is struck off register.

21388855

Robin G

2011

[Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?].

21389086

Wehr E

2011

Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.

21391350

Praz?kov? S

2010

[(TTTTA), polymorphism in the promoter of the CYP11A1 gene in the pathogenesis of polycystic ovary syndrome].

21391472

Wassell J

2011

The value of sex hormone binding globulin (SHBG) in predicting treatment response in polycystic ovary syndrome (PCOS).

21393897

Bhutoria S

2011

Embryonal rhabdomyosarcoma of the adult soft palate.

21398041

Ruta L

2011

Increased serum androstenedione in adults with autism spectrum conditions.

21400443

Greenblatt EM

1995

Laparoscopic ovarian cautery for polycystic ovarian syndrome.

21401530

Battaglia C

2011

Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome.

21403408

Muderris II

2011

Effect of thyroid hormone replacement therapy on ovarian volume and androgen hormones in patients with untreated primary hypothyroidism.

21406133

Bhattacharya S

2010

Female infertility.

21406446

Dolfing JG

2011

Comparison of MRI-assessed body fat content between lean women with polycystic ovary syndrome (PCOS) and matched controls: less visceral fat with PCOS.

21411410

Cekmez F

2011

Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome.

21411543

Savaris RF

2011

Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles.

21411746

Hatzirodos N

2011

Linkage of regulators of TGF-? activity in the fetal ovary to polycystic ovary syndrome.

21413876

Kilicci C

2011

Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.

21413894

Hillman JB

2011

Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients.

21415709

Nazli Y

2011

Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report.

21417594

Minozzi M

2011

The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome.

21417649

Herlihy AC

2011

Polycystic ovary syndrome and the peripheral blood white cell count.

21417650

Ozgun MT

2011

The influence of obesity on ICSI outcomes in women with polycystic ovary syndrome.

21418035

Economou F

2011

The pluripotential effects of hypolipidemic treatment for polycystic ovary syndrome (PCOS): dyslipidemia, cardiovascular risk factors and beyond.

21418339

Sheppard KM

2011

Prenatal programming by testosterone of hypothalamic metabolic control neurones in the ewe.

21419313

Toscani MK

2011

Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.

21419406

Lecke SB

2011

Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome.

21419463

Morrison JA

2011

Adolescent oligomenorrhea in a biracial schoolgirl cohort: a simple clinical parameter predicting impaired fasting glucose plus type 2 diabetes mellitus, insulin, glucose, insulin resistance, and centripetal obesity from age 19 to 25 years.

21419674

Ornstein RM

2011

Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome.

21421016

Barry JA

2011

The impact of eating behavior on psychological symptoms typical of reactive hypoglycemia. A pilot study comparing women with polycystic ovary syndrome to controls.

21424395

Villa J

2011

Adipose tissue dysfunction in polycystic ovary syndrome.

21426455

Lipton RB

2011

Onset features and subsequent clinical evolution of childhood diabetes over several years.

21427116

Hudecova M

2011

Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up.

21427877

Kedikova S

2010

[Adolescent PCOS].

21429814

Zitsman JL

2011

Comparative outcomes of laparoscopic adjustable gastric banding in adolescents and adults.

21429962

Radavelli-Bagatini S

2011

The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function.

21434483

Papaleo E

2011

Myo-inositol products in polycystic ovary syndrome (PCOS) treatment: quality, labeling accuracy, and cost comparison.

21435276

Tehrani FR

2011

The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study.

21436137

Deeks AA

2011

Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression?

21437531

Moura HH

2011

Polycystic ovary syndrome: a dermatologic approach.

21437624

Gomes VA

2011

Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.

21437823

Catenacci M

2011

Transvaginal hydrolaparoscopy.

21437828

Flyckt RL

2011

Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome.

21444075

Ewens KG

2011

Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome.

21446991

Ott J

2011

A modified technique of laparoscopic ovarian drilling for polycystic ovary syndrome using the monopolar hook electrode.

21447274

Lebkowska A

2010

[Polycystic ovary syndrome in type 1 diabetes].

21447694

Amato MC

2011

The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk.

21448847

Mlinar B

2011

Lipin 1 gene polymorphisms in polycystic ovary syndrome.

21450287

Hart R

2011

Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome.

21450291

Karakas S

2011

In search of the LINK: Acute Phase Serum Amyloid A.

21450988

Puurunen J

2011

Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS.

21453749

Repaci A

2011

Ghrelin and reproductive disorders.

21454179

Petr?nyi G

2011

[Metformin treatment with or without life style changes in patients with polycystic ovary syndrome].

21454403

Carbajal L

2011

GPCR/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary.

21454995

Al-Mutairi N

2011

Associated cutaneous diseases in obese adult patients: a prospective study from a skin referral care center.

21457973

Abdellah MS

2011

Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome.

21458334

Altu? ?en T

2011

Homocysteine and ghrelin link with polcystic ovary syndrome in relation to obesity.

21463430

Coksuer H

2011

Evaluation of carotid wall thickness and vertebro-basilar system insufficiency in patients with obese polycystic ovary syndrome.

21466513

Johnson N

2011

Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials.

21467073

Wang X

2011

Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology.

21468515

Marcondes JA

2011

[Difficulties and pitfalls in the diagnosis of polycystic ovary syndrome].

21470277

Lee VC

2011

Aromatase inhibitors for ovulation induction and ovarian stimulation.

21470992

Wehr E

2011

The lipid accumulation product is associated with impaired glucose tolerance in PCOS women.

21471855

Vitonis AF

2011

Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy.

21473679

Barry JA

2011

Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls.

21474127

Gonz?lez-Fern?ndez R

2011

Patients with endometriosis and patients with poor ovarian reserve have abnormal follicle-stimulating hormone receptor signaling pathways.

21474465

Daskalopoulos GN

2011

Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?

21474907

Tao M

2011

Continuous glucose monitoring reveals abnormal features of postprandial glycemic excursions in women with polycystic ovarian syndrome.

21474908

Li C

2011

Melatonin receptor 1A gene polymorphism associated with polycystic ovary syndrome.

21475046

Lembo G

2011

A lesson from polycystic ovarian syndrome: untangling the role of renal sympathetic nervous system on hypertension and insulin resistance.

21475454

Omran MY

2007

Metformin and polycystic ovary syndrome.

21477021

Baba T

2011

Distinctive features of female-to-male transsexualism and prevalence of gender identity disorder in Japan.

21477915

Honnma H

2011

Failure of triggering oocyte maturation with a GnRH agonist in polycystic ovary syndrome: two case reports.

21478180

Hickey M

2011

Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis.

21478181

Lindholm A

2011

No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls.